Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

A zebrafish transgenic model of Ewing's sarcoma reveals conserved mediators of EWS-FLI1 tumorigenesis.

Leacock SW, Basse AN, Chandler GL, Kirk AM, Rakheja D, Amatruda JF.

Dis Model Mech. 2012 Jan;5(1):95-106. doi: 10.1242/dmm.007401. Epub 2011 Oct 6.

2.

Promiscuous partnerships in Ewing's sarcoma.

Sankar S, Lessnick SL.

Cancer Genet. 2011 Jul;204(7):351-65. doi: 10.1016/j.cancergen.2011.07.008. Review.

3.

Ewing's sarcoma oncoprotein EWS-FLI1: the perfect target without a therapeutic agent.

Uren A, Toretsky JA.

Future Oncol. 2005 Aug;1(4):521-8. Review.

PMID:
16556028
4.

EWS-FLI1 in Ewing's sarcoma: real targets and collateral damage.

Ban J, Siligan C, Kreppel M, Aryee D, Kovar H.

Adv Exp Med Biol. 2006;587:41-52. Review.

PMID:
17163154
5.

Oncogenic partnerships: EWS-FLI1 protein interactions initiate key pathways of Ewing's sarcoma.

Erkizan HV, Uversky VN, Toretsky JA.

Clin Cancer Res. 2010 Aug 15;16(16):4077-83. doi: 10.1158/1078-0432.CCR-09-2261. Epub 2010 Jun 14. Review.

6.

Identification of target genes in their native cellular context: an analysis of EWS/FLI in Ewing's sarcoma.

Owen LA, Lessnick SL.

Cell Cycle. 2006 Sep;5(18):2049-53. Epub 2006 Sep 15. Review.

PMID:
16969112
7.

Blocking the road, stopping the engine or killing the driver? Advances in targeting EWS/FLI-1 fusion in Ewing sarcoma as novel therapy.

Kovar H.

Expert Opin Ther Targets. 2014 Nov;18(11):1315-28. doi: 10.1517/14728222.2014.947963. Epub 2014 Aug 27. Review.

PMID:
25162919
8.

Molecular pathogenesis of Ewing sarcoma: new therapeutic and transcriptional targets.

Lessnick SL, Ladanyi M.

Annu Rev Pathol. 2012;7:145-59. doi: 10.1146/annurev-pathol-011110-130237. Epub 2011 Sep 19. Review.

9.

The second European interdisciplinary Ewing sarcoma research summit--A joint effort to deconstructing the multiple layers of a complex disease.

Kovar H, Amatruda J, Brunet E, Burdach S, Cidre-Aranaz F, de Alava E, Dirksen U, van der Ent W, Grohar P, Grünewald TG, Helman L, Houghton P, Iljin K, Korsching E, Ladanyi M, Lawlor E, Lessnick S, Ludwig J, Meltzer P, Metzler M, Mora J, Moriggl R, Nakamura T, Papamarkou T, Radic Sarikas B, Rédini F, Richter GH, Rossig C, Schadler K, Schäfer BW, Scotlandi K, Sheffield NC, Shelat A, Snaar-Jagalska E, Sorensen P, Stegmaier K, Stewart E, Sweet-Cordero A, Szuhai K, Tirado OM, Tirode F, Toretsky J, Tsafou K, Üren A, Zinovyev A, Delattre O.

Oncotarget. 2016 Feb 23;7(8):8613-24. doi: 10.18632/oncotarget.6937. Review.

10.

Therapeutic opportunities in Ewing sarcoma: EWS-FLI inhibition via LSD1 targeting.

Theisen ER, Pishas KI, Saund RS, Lessnick SL.

Oncotarget. 2016 Apr 5;7(14):17616-30. doi: 10.18632/oncotarget.7124. Review.

11.

Peripheral primitive neuroectodermal tumor/Ewing's sarcoma of the craniospinal vault: case reports and review.

Mobley BC, Roulston D, Shah GV, Bijwaard KE, McKeever PE.

Hum Pathol. 2006 Jul;37(7):845-53. Epub 2006 May 19. Review.

PMID:
16784984
12.

Biology of EWS/FLI and related fusion genes in Ewing's sarcoma and primitive neuroectodermal tumor.

May WA, Denny CT.

Curr Top Microbiol Immunol. 1997;220:143-50. Review. No abstract available.

PMID:
9103680
13.

Ewing tumor biology: perspectives for innovative treatment approaches.

Kovar H.

Adv Exp Med Biol. 2003;532:27-37. Review.

PMID:
12908547
14.

Structure-function based molecular relationships in Ewing's sarcoma.

Todorova R.

Biomed Res Int. 2015;2015:798426. doi: 10.1155/2015/798426. Epub 2015 Jan 22. Review.

15.

Ewing tumor: tumor biology and clinical applications.

de Alava E, Pardo J.

Int J Surg Pathol. 2001 Jan;9(1):7-17. Review.

PMID:
11469351
16.

Adamantinoma-like Ewing's sarcoma: genomic confirmation, phenotypic drift.

Bridge JA, Fidler ME, Neff JR, Degenhardt J, Wang M, Walker C, Dorfman HD, Baker KS, Seemayer TA.

Am J Surg Pathol. 1999 Feb;23(2):159-65. Review.

PMID:
9989842
17.

Recent advances in the molecular pathogenesis of Ewing's sarcoma.

Toomey EC, Schiffman JD, Lessnick SL.

Oncogene. 2010 Aug 12;29(32):4504-16. doi: 10.1038/onc.2010.205. Epub 2010 Jun 14. Review.

18.

Ewing sarcoma family of tumors.

Khoury JD.

Adv Anat Pathol. 2005 Jul;12(4):212-20. Review.

PMID:
16096383
19.

The potential for molecular therapeutic targets in Ewing's sarcoma.

McAllister NR, Lessnick SL.

Curr Treat Options Oncol. 2005 Nov;6(6):461-71. Review.

PMID:
16242051
20.

Primary Ewing's sarcoma/primitive neuroectodermal tumor of the kidney: Report of a case diagnosed by fine needle aspiration cytology and confirmed by immunocytochemistry and RT-PCR along with review of literature.

Kumar R, Gautam U, Srinivasan R, Lal A, Sharma U, Nijhawan R, Kumar S.

Diagn Cytopathol. 2012 Aug;40 Suppl 2:E156-61. doi: 10.1002/dc.21717. Epub 2011 May 4. Review.

PMID:
21548122

Supplemental Content

Support Center